Picture Fairtec GmbH Worldwide Event Solutions 600x60px

News > Ireland & UK

Please find below news from the United Kingdom (Great Britain) and the Republic of Ireland as well as about organisations from these countries.

Total search results: 2627 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Canbex Therapeutics Ltd.. (11/4/13). "Press Release: Canbex Therapeutics Commences Phase I Clinical Trial of Lead Product VSN16R as a Potential Treatment for Spasticity in Multiple Sclerosis". London. 2013-11-04
AstraZeneca plc. (11/4/13). "Press Release: A*STAR and AstraZeneca Sign a Research Collaboration Agreement to Develop New Antimicrobial Drugs to Combat Gram-negative Bacterial Infections". 2013-11-04
Antisoma plc. (11/1/13). "Press Release: Result of AGM and Change of Name". Breda. 2013-11-01
AstraZeneca plc. (10/31/13). "Press Release: Marc Dunoyer Appointed Chief Financial Officer of AstraZeneca". 2013-10-31
Immunocore Ltd.. (10/31/13). "Press Release: Immunocore Initiates Phase IIa Clinical Trial for IMCgp100 in Melanoma". Oxford. 2013-10-31
Proteome Sciences plc. (10/30/13). "Press Release: Proteome Sciences Appoints Director of Personalised Medicine". 2013-10-30
Almac Group Ltd.. (10/29/13). "Press Release: Richard Segiel, Jr. Joins Almac as Vice President of US Business Development". 2013-10-29
GlaxoSmithKline plc. (10/25/13). "Press Release: ViiV Healthcare Announces European Regulatory Submission for a Single-tablet Regimen Combining Dolutegravir with Abacavir and Lamivudine for People Living with HIV". London. 2013-10-25
Cancer Research UK. (10/24/13). "Press Release: Cancer Imaging Centres Get £35 Million Boost". 2013-10-24
GlaxoSmithKline plc. (10/23/13). "Press Release: Results Announcement for the Third Quarter 2013. GSK Announces Q3 Core EPS Growth of 16% and Dividend of 19p". 2013-10-23
Almac. (10/22/13). "Press Release: Novozymes Biopharma Announces Collaboration with Almac in Drug Manufacture, Half Life Extension and Targeting Technologies. Combined Service Offers Drug Development Companies Efficiencies in Time and Resource". 2013-10-22
AstraZeneca plc. (10/22/13). "Press Release: AstraZeneca Initiates Phase III Clinical Programme for Selumetinib, a Treatment in Development for Patients with Advanced or Metastatic Non-small Cell Lung Cancer". 2013-10-22
Ithaka Life Sciences Ltd.. (10/22/13). "Press Release: Ithaka Life Sciences Client CYP Design Ltd Completes Seed Funding Round". 2013-10-22
Peak Scientific Instruments Ltd.. (10/22/13). "Press Release: Peak Scientific Sign Formal OEM Agreement with Bruker’s Chemical and Applied Markets Division". 2013-10-22
Illumina, Inc.. (10/21/13). "Press Release: University of Cambridge, Genomics England Ltd., and Illumina Collaborate to Sequence 10,000 Whole Genome Sequence for National Health Service Patients. Project Will Lay Foundation for Genomic Medicine". Cambrid 2013-10-21
Microsaic Systems plc. (10/21/13). "Press Release: Microsaic Systems Announces Prestigious New Scientific Advisory Group. High Profile Group Members Drawn from Research and Industry". 2013-10-21
AstraZeneca plc. (10/17/13). "Press Release: AstraZeneca Announces »Open Innovation« Research Collaboration with Taiwan’s Research Program for Biopharmaceuticals". Taipei. 2013-10-17
Sygnature Discovery Ltd.. (10/17/13). "Press Release: Sygnature Discovery and Proteros Biostructures Establish Strategic Alliance". Nottingham & Munich. 2013-10-17
University of Manchester. (10/17/13). "Press Release: State-of-the-Art Research Equipment Thanks to Funding Boost". 2013-10-17
AstraZeneca plc. (10/16/13). "Press Release: Harvard’s Wyss Institute and AstraZeneca Announce Collaboration on Organs-on-Chips for Drug Discovery Safety Testing". Boston, MA. 2013-10-16
Sistemic Ltd.. (10/15/13). "Press Release: Sistemic and QCMD Announce an Innovative Collaboration Aimed at Addressing the Need for Quality Assurance and Standardisation in the Cell Therapy Field as the Industry Shows Signs of Maturing". 2013-10-15
Horizon Discovery Ltd.. (10/15/13). "Press Release: Horizon Discovery Receives Share of €5.75M ($7.8M) EU FP7 Grant". Cambridge. 2013-10-15
Crown Bioscience, Inc.. (10/14/13). "Press Release: Crown Bioscience Enhances Oncology Research Services with Targeted Beam Radiation Therapy via Business Collaboration with Xstrahl Ltd". Santa Clara, CA. 2013-10-14
AstraZeneca plc. (10/11/13). "Press Release: AstraZeneca Enters Co-promotion Agreement with Janssen in Japan for Innovative Prostate Cancer Treatment". 2013-10-11
IP Group plc. (10/10/13). "Press Release: IP Group plc Completes £5m Investment in Cambridge Innovation Capital – Signs MoU to Facilitate Access to Co-investment Opportunities". 2013-10-10
Cambridge Enterprise. (10/10/13). "Press Release: £50 Million of New Funding to Support Cambridge Companies". 2013-10-10
Heptares Therapeutics Ltd.. (10/10/13). "Press Release: Heptares Delivers First Stabilised GPCR (STaR) to MorphoSys for Antibody Discovery". Welwyn Garden City & Boston, MA. 2013-10-10
Oxford Nanopore Technologies Ltd.. (10/9/13). "Press Release: Oxford Nanopore Announces £40 Million ($64 Million) Fundraising". 2013-10-09
Fujifilm Diosynth Biotechnologies UK Ltd.. (10/9/13). "Press Release: Fujifilm Diosynth Biotechnologies’ UK Site Receives Renewed MHRA Manufacturing Licence". Billingham & Norrisville, NC. 2013-10-09
Horizon Discovery Ltd.. (10/8/13). "Press Release: Horizon Discovery and Blueprint Medicines Enter Oncology Research Service Agreement. Horizon Will Support and Guide New Targets Discovery". Cambridge. 2013-10-08
Almac. (10/7/13). "Press Release: Almac Launches New [14C]-labelled ADCs Service Offering". 2013-10-07
Fujifilm Diosynth Biotechnologies UK Ltd.. (10/2/13). "Press Release: Fujifilm Diosynth Biotechnologies Opens New Manufacturing Facility". Billingham, Teesside. 2013-10-02
AstraZeneca plc. (10/1/13). "Press Release: AstraZeneca Welcomes New Arrivals as Alderley Park BioHub Expands". 2013-10-01
Activiomics Ltd.. (9/30/13). "Press Release: Activiomics Extends Capability to Clinical Biomarker Discovery and Appoints CEO". London. 2013-09-30
Malvern Instruments Ltd.. (9/30/13). "Press Release: Malvern Instruments Acquires Nanoparticle Characterization Company NanoSight". 2013-09-30
Microsaic Systems plc. (9/27/13). "Press Release: Interim Results for the Six Months Ended 30 June 2013". 2013-09-27
Dotmatics Ltd.. (9/24/13). "Press Release: Dotmatics Unveils Connection between Thomson Reuters’ Cortellis and Vortex. Dotmatics’ Vortex Provides a Means to Search, Visualize and Analye Thomson Reuters’ Cortellis Database". Bishops Stortford. 2013-09-24
BioOutsource Ltd.. (9/20/13). "Press Release: BioOutsource Launches Comprehensive Range of Off-the-Shelf Testing Methodologies to Support Biosimilar Characterization and Comparability Testing". Boston, MA & Glasgow. 2013-09-20
BioFocus. (9/19/13). "Press Release: Activiomics Extends Research Agreement with Kyowa Hakko Kirin as Part of Its Strategic Partnership with BioFocus". 2013-09-19
Linguamatics Ltd.. (9/19/13). "Press Release: Linguamatics Enhances Access to Content with Latest Release of Text Mining Platform". Cambridge & Boston, MA. 2013-09-19
Abcodia Ltd.. (9/18/13). "Press Release: Abcodia Licenses the »Risk of Ovarian Cancer Algorithm« (ROCA) from Massachusetts General Hospital and Queen Mary, University of London". 2013-09-18
EpimiRNA Consortium. (9/18/13). "Press Release: EpimiRNA Consortium Receives €11.5 Million Funding by EU to Uncover the Effects of microRNA in Epilepsy". 2013-09-18
Ubiquigent Ltd.. (9/18/13). "Press Release: Ubiquigent Announces £0.5M Funding and Strenghtens Board of Directors with Key Appointment". Dundee. 2013-09-18
XO1 Ltd.. (9/17/13). "Press Release: Global Thought-leaders in Anticoagulation Join X01 Scientific Advisory Board, Richard Mason Appointed CEO". Cambridge. 2013-09-17
EMA (European Medicines Agency). (9/16/13). "Press Release: European Medicines Agency Reveals New Structure". 2013-09-16
Horizon Discovery Ltd.. (9/16/13). "Press Release: Horizon Discovery Licenses CRISPR Gene Editing Technology from Harvard University. Gene Editing Platform Now Includes rAAV, ZFN and CRISPR". Cambridge. 2013-09-16
Midatech Ltd.. (9/16/13). "Press Release: Midatech Appoints Dr Jim Phillips as Chief Executive Officer". 2013-09-16
Molecular Profiles Ltd.. (9/12/13). "Press Release: Columbia Laboratories Acquires Molecular Profiles Ltd.". Boston, MA & Nottingham. 2013-09-12
Quay Pharma. (9/12/13). "Press Release: Michael Kruidenier Joins Quay as European Business Development Manager". 2013-09-12
Egalet Ltd.. (9/12/13). "Press Release: Egalet Announces Financing to Fund Abuse-deterrent Medications. Two Lead Programs to Enter Pivotal Trials". Malvern, PA. 2013-09-12
AstraZeneca plc. (9/11/13). "Press Release: AstraZeneca and Merck Enter Licence Agreement for Investigational Oral WEE1 Kinase Inhibitor Therapy for Cancer". 2013-09-11
AstraZeneca plc. (9/10/13). "Press Release: AstraZeneca and Hadasit Announce Drug Discovery Alliance". Jerusalem. 2013-09-10
Edinburgh Instruments Ltd.. (9/9/13). "Press Release: Edinburgh Instruments Appoints New CEO". Livingston. 2013-09-09
PolyTherics Ltd.. (9/9/13). "Press Release: PolyTherics Appoints Julian Smith as Chief Financial Officer". London. 2013-09-09
Arrayjet Ltd.. (9/6/13). "Press Release: Agreement with GMI Inc to Increase Servicing and Support Capacity in North America". 2013-09-06
Canbex Therapeutics Ltd.. (9/6/13). "Press Release: Canbex Therapeutics Secures TSB Biocatalyst Grant". London. 2013-09-06
Vapourtec. (9/5/13). "Press Release: Vapourtec Pump Key to Organometallic Process". 2013-09-05
GlaxoSmithKline plc. (9/5/13). "Press Release: The Investigational MAGE-A3 Antigen-specific Cancer Immunotherapeutic Does Not Meet First Co-primary Endpoint in Phase III Melanoma Clinical Trial". London. 2013-09-05
AstraZeneca plc. (9/4/13). "Press Release: AstraZeneca Initiates Phase III Clinical Programme for Olaparib, a Treatment in Development for Patients with BRCA Mutated Ovarian Cancer". 2013-09-04
Horizon Discovery Ltd.. (9/3/13). "Press Release: Horizon Discovery Licenses Zinc Finger Nuclease Gene Editing Technology from Sigma-Aldrich". Cambridge. 2013-09-03
Genedata AG. (9/3/13). "Press Release: Genedata Screener Extends Support for High-throughput Thermofluor Assays". Basel. 2013-09-03
Acacia Pharma Ltd.. (9/3/13). "Press Release: Acacia Pharma Raises £15m ($23.5m) to Advance Clinical Development of Lead Products". Cambridge. 2013-09-03
Agilent Technologies Inc.. (9/2/13). "Press Release: Agilent Technologies and Marine Institute to Host Research and Technology Workshop in Galway, Ireland". Cork. 2013-09-02
GlaxoSmithKline plc. (9/2/13). "Press Release: GSK Receives Marketing Authorisation from the European Commission for Tafinlar (dabrafenib), an Oral Treatment for Unresectable or Metastatic Melanoma in Adult Patients with a BRAF V600 Mutation". London. 2013-09-02
Nonlinear Dynamics Ltd.. (9/2/13). "Blog: Nonlinear Dynamics at the 12th HUPO World Congress". 2013-09-02
Eagle Genomics Ltd.. (9/2/13). "Press Release: Eagle Genomics Secures £590,000 to Expand Its Current Bioinformatics Offerings". Cambridge, UK. 2013-09-02
Gel Repairer Ltd.. (9/2/13). "Press Release: Gel Repairer Ltd. Off to a Good Start to Change Lives to Millions of Patients in Osteoarthritis". 2013-09-02
Kymab Ltd.. (9/2/13). "Press Release: Kymab Appoints Dr Christian Groendahl as Chief Executive Officer and Dr David Chiswell as Chairman". Cambridge. 2013-09-02
Agilent Technologies Inc.. (8/29/13). "Press Release: Agilent Technologies Invites Mass Spectrometry Users to September Training Workshops in England". Wokingham. 2013-08-29
Desktop Genetics Ltd.. (8/27/13). "Press Release: Desktop Genetics Ltd Receives £375,000 Funding to Commercialize Genetic Engineering Platform AutoClone". London. 2013-08-27
Arrayjet Ltd.. (8/27/13). "Press Release: Alan Faichney Joins the Board of Arrayjet as Non-executive Chairman". 2013-08-27
Covidien plc. (8/27/13). "Press Release: Covidien Opens US$21 Million Research & Development and Training & Education Center in South Korea". Seoul. 2013-08-27
GlaxoSmithKline plc. (8/23/13). "Press Release: GSK Announces Phase III Study of Vercirnon in Patients with Moderate-to-Severe Crohn’s Disease Did Not Meet Its Primary Endpoint". London. 2013-08-23
Cresset Biomolecular Discovery Ltd.. (8/22/13). "Press Release: Cresset Grows Scientific Team and Relocates to Offices in Cambridge Cluster". Cambridge. 2013-08-22
Aquila BioMedical. (8/22/13). "Press Release: Aquila BioMedical Has Found a New Home in Nine, The BioQuarter". 2013-08-22
Hikma Pharmaceuticals plc. (8/21/13). "Press Release: Hikma Delivers Exceptionally Strong First Half Results with 20% Revenue Growth and 156% Increase in Adjusted EPS". London. 2013-08-21
Thermo Fisher Scientific Inc.. (8/15/13). "Press Release: Thermo Fisher Scientific Establishes Pesticide Analysis Center of Excellence". San José, CA. 2013-08-15
XstalBio Ltd.. (8/12/13). "Press Release: XstalBio Launches CentuRecon to Accelerate the Delivery of Biologic Drugs at High Concentration". Glasgow. 2013-08-12
XstalBio Ltd.. (8/9/13). "Press Release: XstalBio Awarded a SMART Grant to Focus on Development of Mucosal Targeted Vaccines for Livestock Parasites". 2013-08-09
Epistem plc. (8/8/13). "Press Release: Epistem Receives a Prestigious FP7 Grant Award for the Development of Point of Care Hepatitis C Assays". Manchester. 2013-08-08
ReNeuron Group plc. (8/7/13). "Press Release: Results of General Meeting". Guildford. 2013-08-07
Source BioScience plc. (8/7/13). "Press Release: Announcement of Open Offer to Raise up to Approximately £1 Million before Expenses through the Issue of up to 10,778,066 New Ordinary Shares [Not for United States, Canada, Australia, Japan, South Africa a 2013-08-07
Source BioScience plc. (8/7/13). "Press Release: Recommended Cash Offer for Vindon Healthcare plc [Not for any jurisdiction where it would constitut a violation of relevant laws of such jurisdition]". 2013-08-07
Wilex AG. (8/7/13). "Press Release: Wilex Starts Clinical Phase I Trial with PI3K Inhibitor WX-037". Munich. 2013-08-07
Dotmatics Ltd.. (8/6/13). "Press Release: UCB to Enhance Informatics Environment with Dotmatics’ Vortex". 2013-08-06
TVM Life Science Ventures. (8/6/13). "Press Release: TVM Life Science Ventures VII Announces Investment in Ixchelsis Ltd.". Montréal, QC. 2013-08-06
Markes International Ltd.. (8/5/13). "Press Release: Markes International Prepares for Further Global Expansion by Strengthening Management Team". Llantrisant. 2013-08-05
Carl Zeiss AG. (8/5/13). "Press Release: Next Generation EVO Delivers Workflow Automation and High Definition Imaging. Advances to the Scanning Electron Microscope Zeiss EVO Presented at Microscopy and Microanalysis 2013". Cambridge & Jena. 2013-08-05
AstraZeneca plc. (8/1/13). "Press Release: AstraZeneca plc. Second Quarter and Half Year Results 2013". London. 2013-08-01
AstraZeneca plc. (8/1/13). "Press Release: Development Pipeline as at 30 June 2013". London. 2013-08-01
ReNeuron Group plc. (8/1/13). "Press Release: ReNeuron Wins £1.5 Million UK Government Grant for Phase II Stroke Trial". Guildford. 2013-08-01
AstraZeneca plc. (7/31/13). "Press Release: AstraZeneca and FibroGen Collaborate to Develop and Commercialise FG-4592, a Treatment for Anaemia in Chronic Kidney Disease and End-stage Renal Disease". 2013-07-31
PolyTherics Ltd.. (7/26/13). "Press Release: PolyTherics and Antitope Combine to Create Leading Provider of Solutions to Enable the Development of Better Biopharmaceuticals. PolyTherics Receives New Investment to Accelerate Growth". London & Cambridge. 2013-07-26
Cell Medica Ltd.. (7/26/13). "Press Release: Cell Medica Announces Completion of Patient Recruitment in the Randomized Cytomegalovirus, CMV~ACE/ASPECT study". London. 2013-07-26
Dotmatics Ltd.. (7/25/13). "Press Release: Dotmatics Cloud Hosted Platform Enables AstraZeneca Neuroscience Drug Discovery Collaborations. Dotmatics Provides Real Time Environment for Partnerships". Bishops Stortford. 2013-07-25
GE Healthcare. (7/25/13). "Press Release: Eurofins Panlabs Strenghtens Drug Disovery Services with GE Healthcare’s Cytiva Cardiomyocytes". Chalfont St. Giles. 2013-07-25
Retroscreen Virology Group plc. (7/25/13). "Press Release: Retroscreen Opens New Manchester Facility". 2013-07-25
Consilium Strategic Communications Ltd.. (7/25/13). "Press Release: Consilium Strategic Communications Company Launch. Europe’s Only Healthcare Specialist Financial PR and IR Firm Launched Today". London. 2013-07-25
Novartis AG. (7/24/13). "Press Release: UK Children Remain Unnecessarily at Risk for Life-threatening and Disabling Meningitis B Disease, Following JCVI Interim Recommendation on Novartis Bexsero Vaccine". Basel. 2013-07-24
GlaxoSmithKline plc. (7/24/13). "Press Release: Results Announcement for the Second Quarter and Interim Management Report for the Half-year 2013. GSK Delivers Q2 2013 Core EPS Growth of 4% on Sales Growth of 2% (both CER)". London. 2013-07-24
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page


Picture [LSUS] – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px

» top